Treatment Sequencing in HR+ mBC

 

Treatment Sequencing in HR+ mBC
18:52

PrecisCa

Expert Case Discussion: 68 y/o With HR+/HER2- mBC With Progression to TNBC

FEATURING Reshma L. Mahtani, William Gradishar, Joyce O'Shaughnessy
  • 160 views
  • August 18, 2023
  • 2
04:37

Christine Brezden-Masley

ADCs in ER+/HER2- mBC

  • 70 views
  • August 3, 2023
  • 1
24:23

OncoAlert

ADCs for BC: Current Clinical Evidence

FEATURING Hope Rugo
  • 266 views
  • July 5, 2023
  • 5
01:46

Dana-Farber Cancer Institute

ASCO® 2023 Insights: "TROPiCS-02 Final OS Analysis of Sacituzumab Govitecan in Pts With HR+/HER2- mBC"

FEATURING Sara Tolaney
  • 166 views
  • June 14, 2023
  • 1
11:31

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, TROPICS-02, and DESTINY-PANTUMOR-02"

FEATURING Paolo Tarantino
  • 6,474 views
  • June 12, 2023
  • 32
23:58

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "mBC Expert Panel Discussion on Key Trials Including SONIA & PALMIRA"

FEATURING Hope Rugo, Komal Jhaveri
  • 1,902 views
  • June 9, 2023
  • 14
08:00

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary Efficacy Analyses of NeoRHEA, Neoadjuvant Biomarker Research Study of Palbociclib Combined With ET in ER+/HER2- BC"

FEATURING Michail Ignatiadis
  • 207 views
  • June 9, 2023
  • 2
09:32

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "TROPiCS-02 Phase 3 Study Final OS Analysis - Sacituzumab Govitecan in Pts With HR+/HER2- mBC"

FEATURING Sara Tolaney
  • 685 views
  • June 7, 2023
  • 6
12:48

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Association of Tumor-Infiltrating Lymphocytes With Clinicopathologic Characteristics and Prognosis in Young Women With HR+/HER2- BC"

FEATURING Megan Tesch
  • 113 views
  • June 7, 2023
  • 2